Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
- Published In:
- Diabetes care, 39(10), 1693-701 (2016)
- Authors:
- Ahrén, Bo, Hirsch, Irl B, Pieber, Thomas R, Mathieu, Chantal, Gómez-Peralta, Fernando, Hansen, Troels Krarup, Philotheou, Areti, Birch, Sune, Christiansen, Erik, Jensen, Thomas Jon, Buse, John B
- Database ID:
- RPEP-02860
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02860APA
Ahrén, Bo; Hirsch, Irl B; Pieber, Thomas R; Mathieu, Chantal; Gómez-Peralta, Fernando; Hansen, Troels Krarup; Philotheou, Areti; Birch, Sune; Christiansen, Erik; Jensen, Thomas Jon; Buse, John B. (2016). Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.. Diabetes care, 39(10), 1693-701. https://doi.org/10.2337/dc16-0690
MLA
Ahrén, Bo, et al. "Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.." Diabetes care, 2016. https://doi.org/10.2337/dc16-0690
RethinkPeptides
RethinkPeptides Research Database. "Efficacy and Safety of Liraglutide Added to Capped Insulin T..." RPEP-02860. Retrieved from https://rethinkpeptides.com/research/ahren-2016-efficacy-and-safety-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.